DNA and proliferating cell machinery

DNA and general proliferating cell machinery refers to the collective molecular components essential for DNA replication, repair, and cell division [National Cancer Institute]. This broad target category encompasses the DNA molecule itself, enzymes such as DNA polymerases and topoisomerases, and structural proteins like tubulin that form the mitotic spindle [StatPearls]. In oncology, these components are the primary targets of traditional cytotoxic chemotherapy, which aims to disrupt the rapid division characteristic of malignant cells [PubMed]. While effective at inducing apoptosis in cancer cells, drugs targeting this machinery often lack specificity, leading to significant side effects in healthy, rapidly dividing tissues such as the bone marrow and gastrointestinal tract [American Cancer Society]. Modern pharmacology often seeks more specific inhibitors within this machinery, such as PARP inhibitors or specific cell cycle kinase inhibitors, to improve the therapeutic index [Nature Reviews Cancer].

Other names

Cell cycle machineryDNA replication apparatusMitotic machineryCytotoxic targetsDNA and replication enzymes

Drugs targeting this machinery act through DNA alkylation, interstrand and intrastrand cross-linking, inhibition of essential nucleotide synthesis (antimetabolites), inhibition of topoisomerase-mediated DNA unwinding, or the stabilization/destabilization of microtubules to arrest mitosis [StatPearls, National Cancer Institute].